nodes	percent_of_prediction	percent_of_DWPC	metapath
Vigabatrin—GABBR1—GPCRs, Class C Metabotropic glutamate, pheromone—GRM4—bone cancer	0.0584	0.249	CbGpPWpGaD
Vigabatrin—GABBR1—GPCRs, Class C Metabotropic glutamate, pheromone—GRM1—bone cancer	0.0507	0.216	CbGpPWpGaD
Vigabatrin—GABBR1—Class C/3 (Metabotropic glutamate/pheromone receptors)—GRM4—bone cancer	0.0267	0.114	CbGpPWpGaD
Vigabatrin—GABBR1—Class C/3 (Metabotropic glutamate/pheromone receptors)—GRM1—bone cancer	0.0231	0.0986	CbGpPWpGaD
Vigabatrin—GABBR1—G alpha (i) signalling events—GRM4—bone cancer	0.00647	0.0276	CbGpPWpGaD
Vigabatrin—GABBR1—G alpha (i) signalling events—RGS1—bone cancer	0.00647	0.0276	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—GRM4—bone cancer	0.00392	0.0167	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.00352	0.015	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—GRM1—bone cancer	0.00339	0.0145	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.00304	0.013	CbGpPWpGaD
Vigabatrin—GABBR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.00272	0.0116	CbGpPWpGaD
Vigabatrin—ABAT—Transmission across Chemical Synapses—BRAF—bone cancer	0.0024	0.0103	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—SMO—bone cancer	0.00239	0.0102	CbGpPWpGaD
Vigabatrin—GABBR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.00228	0.00972	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—GRM4—bone cancer	0.00221	0.00944	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—RGS1—bone cancer	0.00221	0.00944	CbGpPWpGaD
Vigabatrin—Diplopia—Epirubicin—bone cancer	0.00213	0.00278	CcSEcCtD
Vigabatrin—Myalgia—Cisplatin—bone cancer	0.00212	0.00277	CcSEcCtD
Vigabatrin—Anxiety—Cisplatin—bone cancer	0.00212	0.00276	CcSEcCtD
Vigabatrin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	0.00211	0.00275	CcSEcCtD
Vigabatrin—Discomfort—Cisplatin—bone cancer	0.0021	0.00274	CcSEcCtD
Vigabatrin—Increased appetite—Doxorubicin—bone cancer	0.00209	0.00274	CcSEcCtD
Vigabatrin—Affect lability—Epirubicin—bone cancer	0.00209	0.00273	CcSEcCtD
Vigabatrin—Breast disorder—Methotrexate—bone cancer	0.00205	0.00268	CcSEcCtD
Vigabatrin—Face oedema—Epirubicin—bone cancer	0.00205	0.00268	CcSEcCtD
Vigabatrin—Toxic epidermal necrolysis—Methotrexate—bone cancer	0.00205	0.00267	CcSEcCtD
Vigabatrin—GABBR1—Transmission across Chemical Synapses—BRAF—bone cancer	0.00204	0.00872	CbGpPWpGaD
Vigabatrin—Purpura—Doxorubicin—bone cancer	0.00204	0.00267	CcSEcCtD
Vigabatrin—Oedema—Cisplatin—bone cancer	0.00204	0.00266	CcSEcCtD
Vigabatrin—Infection—Cisplatin—bone cancer	0.00202	0.00264	CcSEcCtD
Vigabatrin—Mood swings—Epirubicin—bone cancer	0.00201	0.00263	CcSEcCtD
Vigabatrin—ABAT—Transmission across Chemical Synapses—MDM2—bone cancer	0.00201	0.00859	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—GRM4—bone cancer	0.00201	0.00857	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—RGS1—bone cancer	0.00201	0.00857	CbGpPWpGaD
Vigabatrin—Lethargy—Doxorubicin—bone cancer	0.00201	0.00262	CcSEcCtD
Vigabatrin—Ataxia—Epirubicin—bone cancer	0.002	0.00261	CcSEcCtD
Vigabatrin—Nervous system disorder—Cisplatin—bone cancer	0.002	0.00261	CcSEcCtD
Vigabatrin—Skin disorder—Cisplatin—bone cancer	0.00198	0.00258	CcSEcCtD
Vigabatrin—Gastrointestinal haemorrhage—Doxorubicin—bone cancer	0.00197	0.00257	CcSEcCtD
Vigabatrin—Diplopia—Doxorubicin—bone cancer	0.00197	0.00257	CcSEcCtD
Vigabatrin—Osteoarthritis—Doxorubicin—bone cancer	0.00197	0.00257	CcSEcCtD
Vigabatrin—Pain in extremity—Doxorubicin—bone cancer	0.00197	0.00257	CcSEcCtD
Vigabatrin—Abdominal pain upper—Epirubicin—bone cancer	0.00194	0.00254	CcSEcCtD
Vigabatrin—Affect lability—Doxorubicin—bone cancer	0.00194	0.00253	CcSEcCtD
Vigabatrin—Breast disorder—Epirubicin—bone cancer	0.00192	0.00251	CcSEcCtD
Vigabatrin—GABBR1—GPCR downstream signaling—GRM1—bone cancer	0.00192	0.00818	CbGpPWpGaD
Vigabatrin—Toxic epidermal necrolysis—Epirubicin—bone cancer	0.00192	0.0025	CcSEcCtD
Vigabatrin—Nasopharyngitis—Epirubicin—bone cancer	0.0019	0.00248	CcSEcCtD
Vigabatrin—Face oedema—Doxorubicin—bone cancer	0.0019	0.00248	CcSEcCtD
Vigabatrin—Abdominal discomfort—Methotrexate—bone cancer	0.00188	0.00246	CcSEcCtD
Vigabatrin—Mood swings—Doxorubicin—bone cancer	0.00186	0.00243	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Cisplatin—bone cancer	0.00185	0.00242	CcSEcCtD
Vigabatrin—Abdominal distension—Epirubicin—bone cancer	0.00185	0.00242	CcSEcCtD
Vigabatrin—Ataxia—Doxorubicin—bone cancer	0.00185	0.00242	CcSEcCtD
Vigabatrin—ABAT—Neuronal System—BRAF—bone cancer	0.00184	0.00786	CbGpPWpGaD
Vigabatrin—Influenza—Epirubicin—bone cancer	0.00184	0.0024	CcSEcCtD
Vigabatrin—Paraesthesia—Cisplatin—bone cancer	0.00183	0.00239	CcSEcCtD
Vigabatrin—Upper respiratory tract infection—Methotrexate—bone cancer	0.00183	0.00238	CcSEcCtD
Vigabatrin—Erectile dysfunction—Methotrexate—bone cancer	0.00181	0.00236	CcSEcCtD
Vigabatrin—Abdominal pain upper—Doxorubicin—bone cancer	0.0018	0.00235	CcSEcCtD
Vigabatrin—Breast disorder—Doxorubicin—bone cancer	0.00178	0.00232	CcSEcCtD
Vigabatrin—Toxic epidermal necrolysis—Doxorubicin—bone cancer	0.00177	0.00231	CcSEcCtD
Vigabatrin—Decreased appetite—Cisplatin—bone cancer	0.00177	0.00231	CcSEcCtD
Vigabatrin—Bronchitis—Epirubicin—bone cancer	0.00177	0.00231	CcSEcCtD
Vigabatrin—Pneumonia—Methotrexate—bone cancer	0.00176	0.0023	CcSEcCtD
Vigabatrin—Nasopharyngitis—Doxorubicin—bone cancer	0.00176	0.0023	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Cisplatin—bone cancer	0.00176	0.0023	CcSEcCtD
Vigabatrin—Infestation—Methotrexate—bone cancer	0.00175	0.00229	CcSEcCtD
Vigabatrin—Infestation NOS—Methotrexate—bone cancer	0.00175	0.00229	CcSEcCtD
Vigabatrin—Drowsiness—Methotrexate—bone cancer	0.00175	0.00229	CcSEcCtD
Vigabatrin—Depression—Methotrexate—bone cancer	0.00175	0.00228	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—GRM1—bone cancer	0.00174	0.00743	CbGpPWpGaD
Vigabatrin—Pain—Cisplatin—bone cancer	0.00174	0.00227	CcSEcCtD
Vigabatrin—Stevens-Johnson syndrome—Methotrexate—bone cancer	0.00174	0.00227	CcSEcCtD
Vigabatrin—GABBR1—Transmission across Chemical Synapses—MDM2—bone cancer	0.00171	0.00731	CbGpPWpGaD
Vigabatrin—Abdominal distension—Doxorubicin—bone cancer	0.00171	0.00224	CcSEcCtD
Vigabatrin—Upper respiratory tract infection—Epirubicin—bone cancer	0.00171	0.00223	CcSEcCtD
Vigabatrin—Conjunctivitis—Methotrexate—bone cancer	0.0017	0.00222	CcSEcCtD
Vigabatrin—Influenza—Doxorubicin—bone cancer	0.0017	0.00222	CcSEcCtD
Vigabatrin—Feeling abnormal—Cisplatin—bone cancer	0.00168	0.00219	CcSEcCtD
Vigabatrin—Weight increased—Epirubicin—bone cancer	0.00167	0.00219	CcSEcCtD
Vigabatrin—Hepatobiliary disease—Methotrexate—bone cancer	0.00166	0.00216	CcSEcCtD
Vigabatrin—Pneumonia—Epirubicin—bone cancer	0.00165	0.00215	CcSEcCtD
Vigabatrin—Infestation—Epirubicin—bone cancer	0.00164	0.00214	CcSEcCtD
Vigabatrin—Drowsiness—Epirubicin—bone cancer	0.00164	0.00214	CcSEcCtD
Vigabatrin—Infestation NOS—Epirubicin—bone cancer	0.00164	0.00214	CcSEcCtD
Vigabatrin—Bronchitis—Doxorubicin—bone cancer	0.00164	0.00214	CcSEcCtD
Vigabatrin—Stevens-Johnson syndrome—Epirubicin—bone cancer	0.00162	0.00212	CcSEcCtD
Vigabatrin—Body temperature increased—Cisplatin—bone cancer	0.00161	0.0021	CcSEcCtD
Vigabatrin—Neuropathy peripheral—Epirubicin—bone cancer	0.00161	0.0021	CcSEcCtD
Vigabatrin—Conjunctivitis—Epirubicin—bone cancer	0.00159	0.00208	CcSEcCtD
Vigabatrin—Urinary tract infection—Epirubicin—bone cancer	0.00159	0.00208	CcSEcCtD
Vigabatrin—Upper respiratory tract infection—Doxorubicin—bone cancer	0.00158	0.00206	CcSEcCtD
Vigabatrin—GABBR1—Neuronal System—BRAF—bone cancer	0.00157	0.00668	CbGpPWpGaD
Vigabatrin—Hepatobiliary disease—Epirubicin—bone cancer	0.00155	0.00202	CcSEcCtD
Vigabatrin—Weight increased—Doxorubicin—bone cancer	0.00155	0.00202	CcSEcCtD
Vigabatrin—ABAT—Neuronal System—MDM2—bone cancer	0.00154	0.00658	CbGpPWpGaD
Vigabatrin—Sinusitis—Epirubicin—bone cancer	0.00154	0.00201	CcSEcCtD
Vigabatrin—Pneumonia—Doxorubicin—bone cancer	0.00153	0.00199	CcSEcCtD
Vigabatrin—Drowsiness—Doxorubicin—bone cancer	0.00152	0.00198	CcSEcCtD
Vigabatrin—Infestation NOS—Doxorubicin—bone cancer	0.00152	0.00198	CcSEcCtD
Vigabatrin—Infestation—Doxorubicin—bone cancer	0.00152	0.00198	CcSEcCtD
Vigabatrin—Visual impairment—Methotrexate—bone cancer	0.00152	0.00198	CcSEcCtD
Vigabatrin—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.0015	0.00196	CcSEcCtD
Vigabatrin—Hypersensitivity—Cisplatin—bone cancer	0.0015	0.00196	CcSEcCtD
Vigabatrin—Erythema multiforme—Methotrexate—bone cancer	0.00149	0.00194	CcSEcCtD
Vigabatrin—Neuropathy peripheral—Doxorubicin—bone cancer	0.00149	0.00194	CcSEcCtD
Vigabatrin—Conjunctivitis—Doxorubicin—bone cancer	0.00147	0.00193	CcSEcCtD
Vigabatrin—Urinary tract infection—Doxorubicin—bone cancer	0.00147	0.00193	CcSEcCtD
Vigabatrin—Eye disorder—Methotrexate—bone cancer	0.00147	0.00192	CcSEcCtD
Vigabatrin—Tinnitus—Methotrexate—bone cancer	0.00147	0.00191	CcSEcCtD
Vigabatrin—Hypoaesthesia—Epirubicin—bone cancer	0.00146	0.00191	CcSEcCtD
Vigabatrin—Asthenia—Cisplatin—bone cancer	0.00146	0.00191	CcSEcCtD
Vigabatrin—Oedema peripheral—Epirubicin—bone cancer	0.00145	0.00189	CcSEcCtD
Vigabatrin—Connective tissue disorder—Epirubicin—bone cancer	0.00145	0.00189	CcSEcCtD
Vigabatrin—Hepatobiliary disease—Doxorubicin—bone cancer	0.00143	0.00187	CcSEcCtD
Vigabatrin—Sinusitis—Doxorubicin—bone cancer	0.00142	0.00186	CcSEcCtD
Vigabatrin—Visual impairment—Epirubicin—bone cancer	0.00142	0.00185	CcSEcCtD
Vigabatrin—Diarrhoea—Cisplatin—bone cancer	0.00139	0.00182	CcSEcCtD
Vigabatrin—Erythema multiforme—Epirubicin—bone cancer	0.00139	0.00182	CcSEcCtD
Vigabatrin—Mental disorder—Methotrexate—bone cancer	0.00138	0.0018	CcSEcCtD
Vigabatrin—Eye disorder—Epirubicin—bone cancer	0.00137	0.0018	CcSEcCtD
Vigabatrin—Tinnitus—Epirubicin—bone cancer	0.00137	0.00179	CcSEcCtD
Vigabatrin—Malnutrition—Methotrexate—bone cancer	0.00137	0.00179	CcSEcCtD
Vigabatrin—Hypoaesthesia—Doxorubicin—bone cancer	0.00135	0.00177	CcSEcCtD
Vigabatrin—Oedema peripheral—Doxorubicin—bone cancer	0.00134	0.00175	CcSEcCtD
Vigabatrin—Connective tissue disorder—Doxorubicin—bone cancer	0.00134	0.00175	CcSEcCtD
Vigabatrin—Back pain—Methotrexate—bone cancer	0.00132	0.00173	CcSEcCtD
Vigabatrin—GABBR1—Neuronal System—MDM2—bone cancer	0.00131	0.0056	CbGpPWpGaD
Vigabatrin—Visual impairment—Doxorubicin—bone cancer	0.00131	0.00171	CcSEcCtD
Vigabatrin—Vomiting—Cisplatin—bone cancer	0.00129	0.00169	CcSEcCtD
Vigabatrin—Vision blurred—Methotrexate—bone cancer	0.00129	0.00168	CcSEcCtD
Vigabatrin—Mental disorder—Epirubicin—bone cancer	0.00129	0.00168	CcSEcCtD
Vigabatrin—Erythema multiforme—Doxorubicin—bone cancer	0.00129	0.00168	CcSEcCtD
Vigabatrin—Rash—Cisplatin—bone cancer	0.00128	0.00168	CcSEcCtD
Vigabatrin—Dermatitis—Cisplatin—bone cancer	0.00128	0.00167	CcSEcCtD
Vigabatrin—Malnutrition—Epirubicin—bone cancer	0.00128	0.00167	CcSEcCtD
Vigabatrin—Eye disorder—Doxorubicin—bone cancer	0.00127	0.00166	CcSEcCtD
Vigabatrin—Ill-defined disorder—Methotrexate—bone cancer	0.00127	0.00166	CcSEcCtD
Vigabatrin—Tinnitus—Doxorubicin—bone cancer	0.00127	0.00166	CcSEcCtD
Vigabatrin—Anaemia—Methotrexate—bone cancer	0.00126	0.00165	CcSEcCtD
Vigabatrin—Tension—Epirubicin—bone cancer	0.00126	0.00164	CcSEcCtD
Vigabatrin—Nervousness—Epirubicin—bone cancer	0.00124	0.00162	CcSEcCtD
Vigabatrin—Back pain—Epirubicin—bone cancer	0.00124	0.00162	CcSEcCtD
Vigabatrin—GABBR1—GPCR downstream signaling—GNA11—bone cancer	0.00124	0.00527	CbGpPWpGaD
Vigabatrin—Malaise—Methotrexate—bone cancer	0.00123	0.00161	CcSEcCtD
Vigabatrin—Muscle spasms—Epirubicin—bone cancer	0.00123	0.00161	CcSEcCtD
Vigabatrin—Vertigo—Methotrexate—bone cancer	0.00123	0.00161	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—SMO—bone cancer	0.00123	0.00524	CbGpPWpGaD
Vigabatrin—Nausea—Cisplatin—bone cancer	0.00121	0.00158	CcSEcCtD
Vigabatrin—Vision blurred—Epirubicin—bone cancer	0.00121	0.00158	CcSEcCtD
Vigabatrin—Cough—Methotrexate—bone cancer	0.00119	0.00156	CcSEcCtD
Vigabatrin—Mental disorder—Doxorubicin—bone cancer	0.00119	0.00156	CcSEcCtD
Vigabatrin—Ill-defined disorder—Epirubicin—bone cancer	0.00119	0.00155	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—GRM4—bone cancer	0.00119	0.00506	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—RGS1—bone cancer	0.00119	0.00506	CbGpPWpGaD
Vigabatrin—Convulsion—Methotrexate—bone cancer	0.00119	0.00155	CcSEcCtD
Vigabatrin—Malnutrition—Doxorubicin—bone cancer	0.00119	0.00155	CcSEcCtD
Vigabatrin—Anaemia—Epirubicin—bone cancer	0.00118	0.00155	CcSEcCtD
Vigabatrin—Agitation—Epirubicin—bone cancer	0.00118	0.00154	CcSEcCtD
Vigabatrin—Arthralgia—Methotrexate—bone cancer	0.00117	0.00152	CcSEcCtD
Vigabatrin—Chest pain—Methotrexate—bone cancer	0.00117	0.00152	CcSEcCtD
Vigabatrin—Myalgia—Methotrexate—bone cancer	0.00117	0.00152	CcSEcCtD
Vigabatrin—Tension—Doxorubicin—bone cancer	0.00116	0.00152	CcSEcCtD
Vigabatrin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.00116	0.00151	CcSEcCtD
Vigabatrin—Malaise—Epirubicin—bone cancer	0.00115	0.00151	CcSEcCtD
Vigabatrin—Discomfort—Methotrexate—bone cancer	0.00115	0.0015	CcSEcCtD
Vigabatrin—Nervousness—Doxorubicin—bone cancer	0.00115	0.0015	CcSEcCtD
Vigabatrin—Vertigo—Epirubicin—bone cancer	0.00115	0.0015	CcSEcCtD
Vigabatrin—Back pain—Doxorubicin—bone cancer	0.00115	0.0015	CcSEcCtD
Vigabatrin—Muscle spasms—Doxorubicin—bone cancer	0.00114	0.00149	CcSEcCtD
Vigabatrin—Confusional state—Methotrexate—bone cancer	0.00113	0.00147	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—GNA11—bone cancer	0.00112	0.00479	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—IL3—bone cancer	0.00112	0.00478	CbGpPWpGaD
Vigabatrin—Cough—Epirubicin—bone cancer	0.00112	0.00146	CcSEcCtD
Vigabatrin—Vision blurred—Doxorubicin—bone cancer	0.00112	0.00146	CcSEcCtD
Vigabatrin—Convulsion—Epirubicin—bone cancer	0.00111	0.00145	CcSEcCtD
Vigabatrin—Infection—Methotrexate—bone cancer	0.00111	0.00145	CcSEcCtD
Vigabatrin—Ill-defined disorder—Doxorubicin—bone cancer	0.0011	0.00144	CcSEcCtD
Vigabatrin—Nervous system disorder—Methotrexate—bone cancer	0.0011	0.00143	CcSEcCtD
Vigabatrin—Anaemia—Doxorubicin—bone cancer	0.0011	0.00143	CcSEcCtD
Vigabatrin—Chest pain—Epirubicin—bone cancer	0.00109	0.00142	CcSEcCtD
Vigabatrin—Arthralgia—Epirubicin—bone cancer	0.00109	0.00142	CcSEcCtD
Vigabatrin—Myalgia—Epirubicin—bone cancer	0.00109	0.00142	CcSEcCtD
Vigabatrin—Agitation—Doxorubicin—bone cancer	0.00109	0.00142	CcSEcCtD
Vigabatrin—Anxiety—Epirubicin—bone cancer	0.00109	0.00142	CcSEcCtD
Vigabatrin—Skin disorder—Methotrexate—bone cancer	0.00108	0.00142	CcSEcCtD
Vigabatrin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.00108	0.00141	CcSEcCtD
Vigabatrin—Discomfort—Epirubicin—bone cancer	0.00108	0.00141	CcSEcCtD
Vigabatrin—Malaise—Doxorubicin—bone cancer	0.00107	0.0014	CcSEcCtD
Vigabatrin—Vertigo—Doxorubicin—bone cancer	0.00106	0.00139	CcSEcCtD
Vigabatrin—Confusional state—Epirubicin—bone cancer	0.00105	0.00138	CcSEcCtD
Vigabatrin—Oedema—Epirubicin—bone cancer	0.00105	0.00137	CcSEcCtD
Vigabatrin—Infection—Epirubicin—bone cancer	0.00104	0.00136	CcSEcCtD
Vigabatrin—Cough—Doxorubicin—bone cancer	0.00103	0.00135	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—GRM1—bone cancer	0.00103	0.00439	CbGpPWpGaD
Vigabatrin—Convulsion—Doxorubicin—bone cancer	0.00103	0.00134	CcSEcCtD
Vigabatrin—Nervous system disorder—Epirubicin—bone cancer	0.00103	0.00134	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—IL3—bone cancer	0.00102	0.00434	CbGpPWpGaD
Vigabatrin—Musculoskeletal discomfort—Methotrexate—bone cancer	0.00102	0.00133	CcSEcCtD
Vigabatrin—Skin disorder—Epirubicin—bone cancer	0.00102	0.00133	CcSEcCtD
Vigabatrin—Insomnia—Methotrexate—bone cancer	0.00101	0.00132	CcSEcCtD
Vigabatrin—Arthralgia—Doxorubicin—bone cancer	0.00101	0.00132	CcSEcCtD
Vigabatrin—Chest pain—Doxorubicin—bone cancer	0.00101	0.00132	CcSEcCtD
Vigabatrin—Myalgia—Doxorubicin—bone cancer	0.00101	0.00132	CcSEcCtD
Vigabatrin—Anxiety—Doxorubicin—bone cancer	0.00101	0.00131	CcSEcCtD
Vigabatrin—Paraesthesia—Methotrexate—bone cancer	0.001	0.00131	CcSEcCtD
Vigabatrin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.001	0.00131	CcSEcCtD
Vigabatrin—Discomfort—Doxorubicin—bone cancer	0.000997	0.0013	CcSEcCtD
Vigabatrin—Somnolence—Methotrexate—bone cancer	0.000993	0.0013	CcSEcCtD
Vigabatrin—Dyspepsia—Methotrexate—bone cancer	0.000983	0.00128	CcSEcCtD
Vigabatrin—Confusional state—Doxorubicin—bone cancer	0.000975	0.00127	CcSEcCtD
Vigabatrin—Decreased appetite—Methotrexate—bone cancer	0.000971	0.00127	CcSEcCtD
Vigabatrin—Oedema—Doxorubicin—bone cancer	0.000967	0.00126	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Methotrexate—bone cancer	0.000964	0.00126	CcSEcCtD
Vigabatrin—Fatigue—Methotrexate—bone cancer	0.000963	0.00126	CcSEcCtD
Vigabatrin—Infection—Doxorubicin—bone cancer	0.000961	0.00126	CcSEcCtD
Vigabatrin—Pain—Methotrexate—bone cancer	0.000955	0.00125	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000952	0.00124	CcSEcCtD
Vigabatrin—Nervous system disorder—Doxorubicin—bone cancer	0.000948	0.00124	CcSEcCtD
Vigabatrin—Insomnia—Epirubicin—bone cancer	0.000945	0.00123	CcSEcCtD
Vigabatrin—Skin disorder—Doxorubicin—bone cancer	0.000939	0.00123	CcSEcCtD
Vigabatrin—Paraesthesia—Epirubicin—bone cancer	0.000939	0.00123	CcSEcCtD
Vigabatrin—Somnolence—Epirubicin—bone cancer	0.000929	0.00121	CcSEcCtD
Vigabatrin—Feeling abnormal—Methotrexate—bone cancer	0.00092	0.0012	CcSEcCtD
Vigabatrin—Dyspepsia—Epirubicin—bone cancer	0.00092	0.0012	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Methotrexate—bone cancer	0.000913	0.00119	CcSEcCtD
Vigabatrin—Decreased appetite—Epirubicin—bone cancer	0.000909	0.00119	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Epirubicin—bone cancer	0.000902	0.00118	CcSEcCtD
Vigabatrin—Fatigue—Epirubicin—bone cancer	0.000901	0.00118	CcSEcCtD
Vigabatrin—Pain—Epirubicin—bone cancer	0.000894	0.00117	CcSEcCtD
Vigabatrin—Constipation—Epirubicin—bone cancer	0.000894	0.00117	CcSEcCtD
Vigabatrin—Urticaria—Methotrexate—bone cancer	0.000887	0.00116	CcSEcCtD
Vigabatrin—Abdominal pain—Methotrexate—bone cancer	0.000883	0.00115	CcSEcCtD
Vigabatrin—Body temperature increased—Methotrexate—bone cancer	0.000883	0.00115	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000881	0.00115	CcSEcCtD
Vigabatrin—Insomnia—Doxorubicin—bone cancer	0.000875	0.00114	CcSEcCtD
Vigabatrin—Paraesthesia—Doxorubicin—bone cancer	0.000868	0.00113	CcSEcCtD
Vigabatrin—Feeling abnormal—Epirubicin—bone cancer	0.000861	0.00113	CcSEcCtD
Vigabatrin—Somnolence—Doxorubicin—bone cancer	0.00086	0.00112	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Epirubicin—bone cancer	0.000855	0.00112	CcSEcCtD
Vigabatrin—Dyspepsia—Doxorubicin—bone cancer	0.000851	0.00111	CcSEcCtD
Vigabatrin—Decreased appetite—Doxorubicin—bone cancer	0.000841	0.0011	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000835	0.00109	CcSEcCtD
Vigabatrin—Fatigue—Doxorubicin—bone cancer	0.000834	0.00109	CcSEcCtD
Vigabatrin—Urticaria—Epirubicin—bone cancer	0.00083	0.00108	CcSEcCtD
Vigabatrin—Pain—Doxorubicin—bone cancer	0.000827	0.00108	CcSEcCtD
Vigabatrin—Constipation—Doxorubicin—bone cancer	0.000827	0.00108	CcSEcCtD
Vigabatrin—Body temperature increased—Epirubicin—bone cancer	0.000826	0.00108	CcSEcCtD
Vigabatrin—Abdominal pain—Epirubicin—bone cancer	0.000826	0.00108	CcSEcCtD
Vigabatrin—Hypersensitivity—Methotrexate—bone cancer	0.000823	0.00107	CcSEcCtD
Vigabatrin—Asthenia—Methotrexate—bone cancer	0.000801	0.00105	CcSEcCtD
Vigabatrin—Feeling abnormal—Doxorubicin—bone cancer	0.000797	0.00104	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Doxorubicin—bone cancer	0.000791	0.00103	CcSEcCtD
Vigabatrin—Pruritus—Methotrexate—bone cancer	0.00079	0.00103	CcSEcCtD
Vigabatrin—Hypersensitivity—Epirubicin—bone cancer	0.00077	0.00101	CcSEcCtD
Vigabatrin—Urticaria—Doxorubicin—bone cancer	0.000768	0.001	CcSEcCtD
Vigabatrin—Body temperature increased—Doxorubicin—bone cancer	0.000765	0.000999	CcSEcCtD
Vigabatrin—Abdominal pain—Doxorubicin—bone cancer	0.000765	0.000999	CcSEcCtD
Vigabatrin—Diarrhoea—Methotrexate—bone cancer	0.000764	0.000998	CcSEcCtD
Vigabatrin—Asthenia—Epirubicin—bone cancer	0.00075	0.00098	CcSEcCtD
Vigabatrin—Pruritus—Epirubicin—bone cancer	0.00074	0.000966	CcSEcCtD
Vigabatrin—Dizziness—Methotrexate—bone cancer	0.000739	0.000965	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—SMO—bone cancer	0.000725	0.00309	CbGpPWpGaD
Vigabatrin—Diarrhoea—Epirubicin—bone cancer	0.000715	0.000934	CcSEcCtD
Vigabatrin—Hypersensitivity—Doxorubicin—bone cancer	0.000713	0.000931	CcSEcCtD
Vigabatrin—Vomiting—Methotrexate—bone cancer	0.00071	0.000928	CcSEcCtD
Vigabatrin—Rash—Methotrexate—bone cancer	0.000704	0.00092	CcSEcCtD
Vigabatrin—Dermatitis—Methotrexate—bone cancer	0.000704	0.000919	CcSEcCtD
Vigabatrin—Headache—Methotrexate—bone cancer	0.0007	0.000914	CcSEcCtD
Vigabatrin—Asthenia—Doxorubicin—bone cancer	0.000694	0.000906	CcSEcCtD
Vigabatrin—Dizziness—Epirubicin—bone cancer	0.000691	0.000903	CcSEcCtD
Vigabatrin—Pruritus—Doxorubicin—bone cancer	0.000684	0.000894	CcSEcCtD
Vigabatrin—Vomiting—Epirubicin—bone cancer	0.000665	0.000868	CcSEcCtD
Vigabatrin—Nausea—Methotrexate—bone cancer	0.000663	0.000867	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—GNA11—bone cancer	0.000663	0.00283	CbGpPWpGaD
Vigabatrin—Diarrhoea—Doxorubicin—bone cancer	0.000662	0.000864	CcSEcCtD
Vigabatrin—Rash—Epirubicin—bone cancer	0.000659	0.000861	CcSEcCtD
Vigabatrin—Dermatitis—Epirubicin—bone cancer	0.000658	0.00086	CcSEcCtD
Vigabatrin—Headache—Epirubicin—bone cancer	0.000655	0.000855	CcSEcCtD
Vigabatrin—Dizziness—Doxorubicin—bone cancer	0.00064	0.000835	CcSEcCtD
Vigabatrin—Nausea—Epirubicin—bone cancer	0.000621	0.000811	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—ATF1—bone cancer	0.000617	0.00263	CbGpPWpGaD
Vigabatrin—Vomiting—Doxorubicin—bone cancer	0.000615	0.000803	CcSEcCtD
Vigabatrin—Rash—Doxorubicin—bone cancer	0.00061	0.000797	CcSEcCtD
Vigabatrin—Dermatitis—Doxorubicin—bone cancer	0.000609	0.000796	CcSEcCtD
Vigabatrin—Headache—Doxorubicin—bone cancer	0.000606	0.000791	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—IL3—bone cancer	0.000601	0.00256	CbGpPWpGaD
Vigabatrin—Nausea—Doxorubicin—bone cancer	0.000574	0.00075	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—TGFBR2—bone cancer	0.000514	0.00219	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—IGF1R—bone cancer	0.000484	0.00206	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—KIT—bone cancer	0.000351	0.0015	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—BRAF—bone cancer	0.00033	0.00141	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—EGFR—bone cancer	0.00032	0.00136	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—MDM2—bone cancer	0.000276	0.00118	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—JUN—bone cancer	0.00024	0.00102	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—MMP9—bone cancer	0.000234	0.000997	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—EGFR—bone cancer	0.000189	0.000806	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—TP53—bone cancer	0.000159	0.000676	CbGpPWpGaD
